
Samantha L. Shterengarts
Examiner (ID: 8624, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1623, 4131 |
| Total Applications | 2403 |
| Issued Applications | 1806 |
| Pending Applications | 134 |
| Abandoned Applications | 481 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18013258
[patent_doc_number] => 11505540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Salts of a Pim kinase inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/147877
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 31523
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147877 | Salts of a Pim kinase inhibitor | Jan 12, 2021 | Issued |
Array
(
[id] => 18685108
[patent_doc_number] => 11780825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Thyroid hormone receptor agonists and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/147538
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 71840
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147538
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147538 | Thyroid hormone receptor agonists and use thereof | Jan 12, 2021 | Issued |
Array
(
[id] => 17649609
[patent_doc_number] => 11352323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Processes for making, and methods of using, glycopyrronium compounds
[patent_app_type] => utility
[patent_app_number] => 17/145109
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16133
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145109
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145109 | Processes for making, and methods of using, glycopyrronium compounds | Jan 7, 2021 | Issued |
Array
(
[id] => 18312045
[patent_doc_number] => 20230115945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => AMINOPYRIMIDINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/788334
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788334 | AMINOPYRIMIDINE COMPOUNDS | Dec 29, 2020 | Pending |
Array
(
[id] => 18335890
[patent_doc_number] => 20230127839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/789694
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 1806
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789694 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Dec 29, 2020 | Abandoned |
Array
(
[id] => 17227210
[patent_doc_number] => 20210353766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => SULFAMIDE LINKERS FOR USE IN BIOCONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/135703
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/135703 | Sulfamide linkers for use in bioconjugates | Dec 27, 2020 | Issued |
Array
(
[id] => 18268217
[patent_doc_number] => 20230089459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CHEMICAL COMPOUNDS TARGETING THE EYE AND USE THEREOF IN THE TREATMENT OF EYE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/788534
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788534 | Chemical compounds targeting the eye and use thereof in the treatment of eye diseases | Dec 21, 2020 | Issued |
Array
(
[id] => 17726551
[patent_doc_number] => 11382916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/126126
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28769
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126126
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126126 | Fused heterotricyclic organic compounds, pharmaceutical compositions, and medical uses thereof | Dec 17, 2020 | Issued |
Array
(
[id] => 18229376
[patent_doc_number] => 20230068370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 17/757483
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 448
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757483 | COMBINATIONS | Dec 15, 2020 | Pending |
Array
(
[id] => 16868437
[patent_doc_number] => 20210161904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/118706
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118706 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | Dec 10, 2020 | Issued |
Array
(
[id] => 18341851
[patent_doc_number] => 11639325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 17/116427
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 36
[patent_no_of_words] => 11491
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116427 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | Dec 8, 2020 | Issued |
Array
(
[id] => 17035028
[patent_doc_number] => 20210251986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE
[patent_app_type] => utility
[patent_app_number] => 17/108101
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108101 | POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE | Nov 30, 2020 | Abandoned |
Array
(
[id] => 20480353
[patent_doc_number] => 12528824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Biotin-containing monomers and articles formed therefrom
[patent_app_type] => utility
[patent_app_number] => 17/755946
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 9234
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755946 | Biotin-containing monomers and articles formed therefrom | Nov 22, 2020 | Issued |
Array
(
[id] => 18215203
[patent_doc_number] => 11590116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Substituted pyridines and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/949915
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60905
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 453
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16949915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/949915 | Substituted pyridines and methods of use | Nov 19, 2020 | Issued |
Array
(
[id] => 17945709
[patent_doc_number] => 20220332726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => NITROXIDE DERIVATIVE OF ROCK KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/298676
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298676 | NITROXIDE DERIVATIVE OF ROCK KINASE INHIBITOR | Nov 17, 2020 | Abandoned |
Array
(
[id] => 18093051
[patent_doc_number] => 20220411392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Amide Derivative And Preparation Method Therefore And Use Thereof In Medicine
[patent_app_type] => utility
[patent_app_number] => 17/776513
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776513 | Amide derivative and preparation method therefore and use thereof in medicine | Nov 11, 2020 | Issued |
Array
(
[id] => 16671218
[patent_doc_number] => 20210059981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/095876
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17095876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/095876 | COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS | Nov 11, 2020 | Abandoned |
Array
(
[id] => 20578462
[patent_doc_number] => 12570704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Functionally modified maytansinoids and compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/774843
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 41
[patent_no_of_words] => 28229
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774843 | Functionally modified maytansinoids and compositions and methods of use thereof | Nov 4, 2020 | Issued |
Array
(
[id] => 18427583
[patent_doc_number] => 11672782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Carboxamide derivatives
[patent_app_type] => utility
[patent_app_number] => 17/089064
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32689
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089064 | Carboxamide derivatives | Nov 3, 2020 | Issued |
Array
(
[id] => 16628632
[patent_doc_number] => 20210047285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst
[patent_app_type] => utility
[patent_app_number] => 17/087926
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087926 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | Nov 2, 2020 | Issued |